JMP Securities analyst Steven Delaney maintains TPG RE Finance Trust (NYSE:TRTX) with a Market Outperform and lowers the price target from $14.5 to $13.
JMP Securities Maintains Market Outperform on TPG RE Finance Trust, Lowers Price Target to $13
JMP Securities analyst Steven Delaney maintains TPG RE Finance Trust (NYSE:TRTX) with a Market Outperform and lowers the price target from $14.5 to $13.
Related Posts
NeuBase Therapeutics Reports Business Update And Financial Results For Q1 Of FY23; As Of December 31, 2022, The Company Had Cash And Cash Equivalents Of ~$17.4M
NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision
Trustmark Q4 EPS $0.68 Beats $0.57 Estimate
Trustmark (NASDAQ:TRMK) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.57 by 19.3 percent. This is a 61.9 percent increase over earnings of $0.42 per share from the same